431 related articles for article (PubMed ID: 17652740)
1. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
Milikan JC; Kinchington PR; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis.
Milikan JC; Kuijpers RW; Baarsma GS; Osterhaus AD; Verjans GM
Exp Eye Res; 2006 Jul; 83(1):69-75. PubMed ID: 16530754
[TBL] [Abstract][Full Text] [Related]
3. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
Milikan JC; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
Ouwendijk WJ; Geluk A; Smits SL; Getu S; Osterhaus AD; Verjans GM
J Immunol; 2014 Apr; 192(8):3730-9. PubMed ID: 24623134
[TBL] [Abstract][Full Text] [Related]
5. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
8. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
9. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
[TBL] [Abstract][Full Text] [Related]
10. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
[TBL] [Abstract][Full Text] [Related]
11. Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus.
Arvin AM; Sharp M; Moir M; Kinchington PR; Sadeghi-Zadeh M; Ruyechan WT; Hay J
Viral Immunol; 2002; 15(3):507-16. PubMed ID: 12479399
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Toxoplasma gondii-specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis.
Feron EJ; Klaren VN; Wierenga EA; Verjans GM; Kijlstra A
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3228-32. PubMed ID: 11726627
[TBL] [Abstract][Full Text] [Related]
13. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
[TBL] [Abstract][Full Text] [Related]
14. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
15. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
Jenkins DE; Yasukawa LL; Bergen R; Benike C; Engleman EG; Arvin AM
J Immunol; 1999 Jan; 162(1):560-7. PubMed ID: 9886433
[TBL] [Abstract][Full Text] [Related]
16. Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain.
Santos RA; Padilla JA; Hatfield C; Grose C
Virology; 1998 Sep; 249(1):21-31. PubMed ID: 9740773
[TBL] [Abstract][Full Text] [Related]
17. Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete.
Kido S; Sugita S; Horie S; Miyanaga M; Miyata K; Shimizu N; Morio T; Mochizuki M
Br J Ophthalmol; 2008 Apr; 92(4):505-8. PubMed ID: 18245272
[TBL] [Abstract][Full Text] [Related]
18. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.
Vossen MT; Gent MR; Weel JF; de Jong MD; van Lier RA; Kuijpers TW
J Infect Dis; 2004 Jul; 190(1):72-82. PubMed ID: 15195245
[TBL] [Abstract][Full Text] [Related]
19. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.
De Castro N; Carmagnat M; Kernéis S; Scieux C; Rabian C; Molina JM
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1089-97. PubMed ID: 21417759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
